Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate approves measure requiring opioid antagonists at public college residential facilities
Summary
The committee passed Senate File 164 to require Minnesota State and University of Minnesota residential facilities to maintain at least two doses of a nasal opioid antagonist (naloxone) on site; sponsors and testifiers said the change would expand overdose response capacity on campuses.
Senator Weber introduced Senate File 164, asking the Health and Human Services Finance and Policy Committee to require Minnesota’s public postsecondary institutions to keep opioid antagonists on site and provide at least two doses of a nasal antagonist at each campus residential facility.
Weber said the bill responds to rising fentanyl use and overdose risk among college‑age students and that the measure…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
